| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| TEVA Teva Pharmaceutical Industries Limited | 118,589,945,532.15 | 446,456,265,532.8 | 1,293,198,210,417.21 |
| BHC Bausch Health Companies Inc. | 59,213,857,892.25 | 211,612,482,834.66 | 804,464,872,646.82 |
| RDY Dr. Reddy's Laboratories Limited | 3,766,383,413.0 | 102,705,230,335.93 | 197,396,302,215.32 |
| 1795 美時 | 6,325,432,000 | 25,659,301,000 | 108,585,630,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 7,255,368,558.2 | 20,471,804,301.9 | 56,578,143,628.13 |
| 6472 保瑞 | 8,431,018,000 | 24,395,699,000 | 52,077,131,000 |
| SUPN Supernus Pharmaceuticals, Inc. | 5,838,745,955.77 | 23,474,514,701.16 | 46,336,352,537.34 |
| BBIO BridgeBio Pharma, Inc. | 21,995,466,091.83 | 35,467,900,377.33 | 39,496,421,916.92 |
| TSHA Taysha Gene Therapies, Inc. | 14,776,112,537.61 | 14,971,664,275.43 | 15,263,645,375.25 |
| 3705 永信 | 1,681,311,000 | 7,568,539,000 | 13,176,178,000 |
| 1720 生達 | 2,014,373,000 | 5,775,065,000 | 12,315,901,000 |
| 4120 友華 | 1,545,691,000 | 4,035,955,000 | 11,750,301,000 |
| ASMB Assembly Biosciences Inc | 1,047,549,926.53 | 10,641,557,634.95 | 10,734,158,374.91 |
| PSNL Personalis, Inc. | 3,048,880,985.44 | 7,950,944,824.23 | 10,127,516,456.55 |
| 4747 強生* | 261,729,000 | 602,886,000 | 2,558,703,000 |
| 6461 益得 | 95,420,000 | 370,571,000 | 2,295,483,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | 540,614,411.07 | 1,657,371,547.94 | 1,744,164,462.93 |
| CPHI China Pharma Holdings Inc | 9,891,796.63 | 65,106,691.25 | 1,450,655,158.89 |
| 6130 上亞科技 | 75,442,000 | 178,444,000 | 735,886,000 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例